TED Ted Baker Plc

    RNS Number : 4925Y
  Tepnel Life Sciences PLC
  07 July 2008
   

    Tepnel Life Sciences plc ("the Company")

    Holding in Company


    The Company was informed on 3 July 2008 by AXA Investment Managers UK Limited that AXA
    S.A. 25 Avenue Matignon, 75008 Paris and its group companies are interested in
14,530,450 ordinary shares in the Company ("Ordinary Shares") representing 6.31% of the
issued share capital of the Company. These shares are represented by indirect holdings held
by the following: 

 Name of Fund     Number of Shares  % of issued share capital
 AXA Framlington  12,853,581        5.58
 AWF Framlington  1,676,869         0.73
 Health


    For further information:

    Tepnel Life Sciences plc
    Ben Matzilevich, Chief Executive Officer
    Michael Slater, Group Finance Director
    Tel: 0161 946 2200

    Capital MS&L
    Mary Clark or Joanna Whineray
    Tel: +44 20 7307 5330

    Seymour Pierce Limited
    Mark Percy
    Tel: +44 20 7107 8000


    Notes to Editors:

    About Tepnel Life Sciences plc
    Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences products and services Group with two divisions, Molecular
Diagnostics and Research Products & Services. The Company has laboratories, manufacturing and operations in the USA, UK and France with over
200 employees. Tepnel provides test kits, reagents and services to two highly synergistic markets, these being Molecular Diagnostics and
Biomedical Research. The Company's strategy has been to identify high growth niche opportunities within these multi-billion pound markets.
Tepnel focuses on these niche operations with internally developed products, patents, expertise and know-how as well as strategic
acquisitions, to develop a leadership position within these 


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
HOLUBSSRWSRBRAR

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024